DCVC Opportunity Fund II GP, LLC — Q1 2024 13F-HR

← DCVC Opportunity Fund II GP, LLC

Q1 2024 · 13F-HR

DCVC Opportunity Fund II GP, LLCholdings as filed

Filed 2024-05-15 · accession 0001104659-24-061612

$71.4M

Reported value

Positions

2024-03-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
75629V104	RXRX	Recursion Pharmaceuticals, Inc.	$39.4M	55.1%	3,951,141	Common	SOLE
773122106	—	Rocket Lab USA, Inc.	$29.6M	41.4%	7,203,035	Common	SOLE
76655K103	RGTI	Rigetti Computing, Inc.	$2.4M	3.42%	1,599,052	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.